LakeShore Biopharma

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	70.10 k	70.10 k	70.10 k	70.10 k	70.10 k	70.10 k
Cash burn (monthly)	181.95 k	83.75 k	193.73 k	127.32 k	1.93 mm	944.86 k
Cash used (since last report)	5.29 mm	2.44 mm	5.64 mm	3.70 mm	56.20 mm	27.49 mm
Cash remaining	-5.22 mm	-2.37 mm	-5.57 mm	-3.63 mm	-56.13 mm	-27.42 mm
Runway (months of cash)	-28.7	-28.3	-28.7	-28.5	-29.1	-29.0

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

LakeShore Biopharma institutional ownership history Ownership history

6.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	3	3	–
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	0.00	0.00
Total shares	7.45 mm	7.45 mm	–
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Summit Healthcare Acquisition Sponsor	5.30 mm	$0.00	0.0%
Integrated Core Strategies	1.13 mm	$0.00	0.0%
Fitzgerald Securities Cantor	1.03 mm	$0.00	0.0%
Proequities	0.00	$0.00

Largest transactions	Shares	Change
Proequities	0.00
Fitzgerald Securities Cantor	1.03 mm	0.0%
Integrated Core Strategies	1.13 mm	0.0%
Summit Healthcare Acquisition Sponsor	5.30 mm	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.